THE ROLE OF COMPUTED TOMOGRAPHY IN THE DIAGNOSIS OF LUNG ADENOCARCINOMA

Authors

  • Khaldaraliyev Boburjon Student of the Faculty of General Medicine, Tashkent State Medical University, Tashkent,
  • Mahliyo A. Alisherova Assistant of the Department of Medical Radiology, Tashkent State Medical University, Tashkent,

Keywords:

lung adenocarcinoma, computed tomography, low-dose CT, CT semiotics, TNM staging, artificial intelligence, deep learning, differential diagnosis.

Abstract

Lung adenocarcinoma is the most common histological type of lung cancer, occupying a leading position in oncological morbidity and mortality worldwide. This article provides a detailed analysis of the role, capabilities, modern methods, and clinical significance of computed tomography (CT) in the diagnosis of lung adenocarcinoma. CT examination is the "gold standard" for detecting lung adenocarcinoma at early stages, assessing tumor size, local invasion, lymph nodes, and distant metastases. Modern low-dose CT (LDCT) screening programs have reduced lung cancer mortality by 20-25%. CT semiotics characteristic of adenocarcinoma include: ground-glass opacities (GGO), the "spiculation" sign, the "halo" sign, the vacuole sign, and cavitation. CT-based TNM staging is crucial for determining prognosis and selecting treatment tactics. Recently, artificial intelligence and deep learning models (CNN-LSTM-RF) allow for automatic analysis of CT images, distinguishing adenocarcinoma from other histological types with up to 97% accuracy. The article also covers epidemiological indicators in the Central Asian region, differential diagnosis, and future prospects of CT examination.

References

Global Burden of Disease Study 2021. (2024). Global, regional, and national burden of lung cancer and its risk factors, 1990–2021. The Lancet, 404(10458), 1234-1251. https://doi.org/10.1016/S0140-6736(24)01234-5

Schabath, M. B., & Cote, M. L. (2019). Cancer progress and priorities: Lung cancer. Cancer Epidemiology, Biomarkers & Prevention, 28(10), 1563-1579. https://doi.org/10.1158/1055-9965.EPI-19-0221

Bade, B. C., & Dela Cruz, C. S. (2020). Lung cancer 2020: Epidemiology, etiology, and prevention. Clinics in Chest Medicine, 41(1), 1-24. https://doi.org/10.1016/j.ccm.2019.10.001

Thai, A. A., Solomon, B. J., Sequist, L. V., Gainor, J. F., & Heist, R. S. (2021). Lung cancer in never-smokers: Epidemiology, molecular landscape, and clinical implications. The Lancet Respiratory Medicine, 9(8), 913-926. https://doi.org/10.1016/S2213-2600(21)00123-8

Nasim, F., Sabath, B. F., & Eapen, G. A. (2019). Lung cancer. Medical Clinics of North America, 103(3), 463-473. https://doi.org/10.1016/j.mcna.2018.12.006

Goebel, C., Louden, C. L., McKenna, R., Jr., Onugha, O., Wachtel, A., & Long, T. (2019). Diagnosis of non-small cell lung cancer for early stage asymptomatic patients. Cancer Genomics & Proteomics, 16(4), 229-244. https://doi.org/10.21873/cgp.20128

Duma, N., Santana-Davila, R., & Molina, J. R. (2019). Non-small cell lung cancer: Epidemiology, screening, diagnosis, and treatment. Mayo Clinic Proceedings, 94(8), 1623-1640. https://doi.org/10.1016/j.mayocp.2019.01.013

Goldstraw, P., Chansky, K., Crowley, J., Rami-Porta, R., Asamura, H., Eberhardt, W. E. E., ... & International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee. (2016). The IASLC Lung Cancer Staging Project: Proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. Journal of Thoracic Oncology, 11(1), 39-51. https://doi.org/10.1016/j.jtho.2015.09.009

Detterbeck, F. C., Boffa, D. J., Kim, A. W., & Tanoue, L. T. (2017). The eighth edition lung cancer stage classification. Chest, 151(1), 193-203. https://doi.org/10.1016/j.chest.2016.10.010

Henschke, C. I., McCauley, D. I., Yankelevitz, D. F., Naidich, D. P., McGuinness, G., Miettinen, O. S., ... & Early Lung Cancer Action Project. (1999). Early Lung Cancer Action Project: Overall design and findings from baseline screening. The Lancet, 354(9173), 99-105. https://doi.org/10.1016/S0140-6736(99)06093-6

Sobue, T., Moriyama, N., Kaneko, M., Kusumoto, M., Kobayashi, T., Tsuchiya, R., ... & Naruke, T. (2002). Screening for lung cancer with low-dose helical computed tomography: Anti-lung cancer association project. Journal of Clinical Oncology, 20(4), 911-920. https://doi.org/10.1200/JCO.2002.20.4.911

National Lung Screening Trial Research Team. (2011). Reduced lung-cancer mortality with low-dose computed tomographic screening. New England Journal of Medicine, 365(5), 395-409. https://doi.org/10.1056/NEJMoa1102873

de Koning, H. J., van der Aalst, C. M., de Jong, P. A., Scholten, E. T., Nackaerts, K., Heuvelmans, M. A., ... & Oudkerk, M. (2020). Reduced lung-cancer mortality with volume CT screening in a randomized trial. New England Journal of Medicine, 382(6), 503-513. https://doi.org/10.1056/NEJMoa1911793

Panunzio, A., & Sartori, P. (2020). Lung cancer and radiological imaging. Current Radiopharmaceuticals, 13(3), 238-242. https://doi.org/10.2174/1874471013666200523161849

MacMahon, H., Naidich, D. P., Goo, J. M., Lee, K. S., Leung, A. N. C., Mayo, J. R., ... & Bankier, A. A. (2017). Guidelines for management of incidental pulmonary nodules detected on CT images: From the Fleischner Society 2017. Radiology, 284(1), 228-243. https://doi.org/10.1148/radiol.2017161659

Kakeda, S., Korogi, Y., Ohnari, N., Moriya, J., Oda, N., Nishino, K., & Miyamoto, W. (2008). Usefulness of ground-glass attenuation in the differential diagnosis of pulmonary nodules. Radiation Medicine, 26(1), 1-6. https://doi.org/10.1007/s11604-007-0182-8

Farsad, M. (2020). FDG PET/CT in the staging of lung cancer. Current Radiopharmaceuticals, 13(3), 195-203. https://doi.org/10.2174/1874471013666191223153755

Kandathil, A., Kay, F. U., Butt, Y. M., Wachsmann, J. W., & Subramaniam, R. M. (2018). Role of FDG PET/CT in the eighth edition of TNM staging of non-small cell lung cancer. RadioGraphics, 38(7), 2134-2149. https://doi.org/10.1148/rg.2018180060

Alashban, Y. I. (2026). Optimizing lung cancer diagnosis through computed tomography: A radiological perspective. Journal of Radiation Research and Applied Sciences, 19(1), 102105. https://doi.org/10.1016/j.jrras.2025.102105

Shi, Y., Au, J. S., Thongprasert, S., Srinivasan, S., Tsai, C. M., Khoa, M. T., ... & Yang, P. C. (2014). A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer. Journal of Thoracic Oncology, 9(2), 154-162. https://doi.org/10.1097/JTO.0000000000000033

Midha, A., Dearden, S., & McCormack, R. (2015). EGFR mutation incidence in non-small-cell lung cancer: A systematic review and meta-analysis. Journal of Thoracic Oncology, 10(7), 1016-1027. https://doi.org/10.1097/JTO.0000000000000550

Turgunov, Y., Ergeshov, A., Khasanov, U., Tillyashaykhov, M., & Ziyadullaev, S. (2022). Lung cancer epidemiology in Central Asia: A systematic review. Asian Pacific Journal of Cancer Prevention, 23(5), 1453-1461. https://doi.org/10.31557/APJCP.2022.23.5.1453

Alberg, A. J., Brock, M. V., Ford, J. G., Samet, J. M., & Spivack, S. D. (2013). Epidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest, 143(5 Suppl), e1S-e29S. https://doi.org/10.1378/chest.12-2345

Cheng, E. S., Weber, M., Steinberg, J., & Qin Yu, X. (2021). Lung cancer risk in never-smokers: An overview of environmental and genetic factors. Chinese Journal of Cancer Research, 33(5), 548-562. https://doi.org/10.21147/j.issn.1000-9604.2021.05.02

Xue, Y., Wang, L., Zhang, Y., Zhao, Y., & Liu, Y. (2022). Air pollution: A culprit of lung cancer. Journal of Hazardous Materials, 434, 128937. https://doi.org/10.1016/j.jhazmat.2022.128937

Riihimäki, M., Hemminki, A., Fallah, M., Thomsen, H., Sundquist, K., Sundquist, J., & Hemminki, K. (2014). Metastatic sites and survival in lung cancer. Lung Cancer, 86(1), 78-84. https://doi.org/10.1016/j.lungcan.2014.07.020

US Preventive Services Task Force. (2021). Screening for lung cancer: US Preventive Services Task Force recommendation statement. JAMA, 325(10), 962-970. https://doi.org/10.1001/jama.2021.1117

Hansell, D. M., Bankier, A. A., MacMahon, H., McLoud, T. C., Müller, N. L., & Remy, J. (2008). Fleischner Society: Glossary of terms for thoracic imaging. Radiology, 246(3), 697-722. https://doi.org/10.1148/radiol.2462070712

Ren, Y. (2021). Computed tomography based lung function mapping using deep learning for functional lung avoidance radiation therapy [Doctoral dissertation]. University of Michigan.

Travis, W. D., Brambilla, E., Noguchi, M., Nicholson, A. G., Geisinger, K. R., Yatabe, Y., ... & Garg, K. (2011). International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. Journal of Thoracic Oncology, 6(2), 244-285. https://doi.org/10.1097/JTO.0b013e318206a221

Snoeckx, A., Reyntiens, P., Desbuquoit, D., Spinhoven, M. J., Van Schil, P. E., van Meerbeeck, J. P., & Parizel, P. M. (2018). Evaluation of the solitary pulmonary nodule: Size matters, but do not ignore the power of morphology. Insights into Imaging, 9(1), 73-86. https://doi.org/10.1007/s13244-017-0581-2

Lee, H. Y., & Lee, K. S. (2011). Ground-glass opacity nodules: Histopathology, imaging evaluation, and clinical implications. Journal of Thoracic Imaging, 26(2), 106-118. https://doi.org/10.1097/RTI.0b013e3181e3c5c7

Zwirewich, C. V., Vedal, S., Miller, R. R., & Müller, N. L. (1991). Solitary pulmonary nodule: High-resolution CT and radiologic-pathologic correlation. Radiology, 179(2), 469-476. https://doi.org/10.1148/radiology.179.2.2014296

Onn, A., Choe, D. H., Herbst, R. S., Correa, A. M., Munden, R. F., Truong, M. T., ... & Kim, E. S. (2005). Tumor cavitation in stage I non-small cell lung cancer: Epidermal growth factor receptor expression and prediction of poor outcome. Radiology, 237(1), 342-347. https://doi.org/10.1148/radiol.2371041650

Amin, M. B., Edge, S. B., Greene, F. L., Byrd, D. R., Brookland, R. K., Washington, M. K., ... & Meyer, L. R. (Eds.). (2017). AJCC cancer staging manual (8th ed.). Springer.

Ebner, L., Christodoulidis, S., Butz, S., Rüdiger, S., Friedland, P., Schachtner, B., ... & Ebner, F. (2021). CT-based radiomics for the prediction of visceral pleural invasion in non-small cell lung cancer. European Radiology, 31(8), 6015-6024. https://doi.org/10.1007/s00330-020-07647-2

Silvestri, G. A., Gonzalez, A. V., Jantz, M. A., Margolis, M. L., Gould, M. K., Tanoue, L. T., ... & Detterbeck, F. C. (2013). Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest, 143(5 Suppl), e211S-e250S. https://doi.org/10.1378/chest.12-2355

Quint, L. E., Tummala, S., Brisson, L. J., Francis, I. R., Krupinski, E. A., Kazerooni, E. A., ... & Iannettoni, M. D. (1996). Distribution of distant metastases from newly diagnosed non-small cell lung cancer. The Annals of Thoracic Surgery, 62(1), 246-250. https://doi.org/10.1016/0003-4975(96)00231-1

Modini, C., Passariello, R., Iascone, C., Cicconetti, F., Simonetti, G., Zerilli, M., ... & Stipa, S. (1982). TNM staging in lung cancer: Role of computed tomography. The Journal of Thoracic and Cardiovascular Surgery, 84(4), 569-574.

Wu, N., Phang, J., Park, J., Shen, Y., Huang, Z., Zorin, M., ... & Geras, K. J. (2020). Deep neural networks improve radiologists' performance in breast cancer screening. IEEE Transactions on Medical Imaging, 39(4), 1184-1194. https://doi.org/10.1109/TMI.2019.2945514

Shah, A. A., Malik, H. A. M., Muhammad, A. H., Alourani, A., & Butt, Z. A. (2023). Deep learning ensemble 2D CNN approach towards the detection of lung cancer. Scientific Reports, 13(1), 1-15. https://doi.org/10.1038/s41598-023-29656-z

Saha, A., Ganie, S. M., Pramanik, P. K. D., Yadav, R. K., Mallik, S., & Zhao, Z. (2024). VER-Net: A hybrid transfer learning model for lung cancer detection using CT scan images. BMC Medical Imaging, 24(1), 1-18. https://doi.org/10.1186/s12880-024-01238-z

Gillies, R. J., Kinahan, P. E., & Hricak, H. (2016). Radiomics: Images are more than pictures, they are data. Radiology, 278(2), 563-577. https://doi.org/10.1148/radiol.2015151169

Lambin, P., Leijenaar, R. T. H., Deist, T. M., Peerlings, J., de Jong, E. E. C., van Timmeren, J., ... & Walsh, S. (2017). Radiomics: The bridge between medical imaging and personalized medicine. Nature Reviews Clinical Oncology, 14(12), 749-762. https://doi.org/10.1038/nrclinonc.2017.141

Thawani, R., McLane, M., Beig, N., Ghose, S., Prasanna, P., Velcheti, V., & Madabhushi, A. (2018). Radiomics and radiogenomics in lung cancer: A review for the clinician. Lung Cancer, 115, 34-41. https://doi.org/10.1016/j.lungcan.2017.10.015

Thong, L. T., Chou, H. S., Chew, H. S. J., & Lau, Y. (2023). Diagnostic test accuracy of artificial intelligence-based imaging for lung cancer screening: A systematic review and meta-analysis. Lung Cancer, 176, 4-13. https://doi.org/10.1016/j.lungcan.2022.12.002

Liu, Y., Brailsford, T., & Bull, L. (2025). ResNet18 performance: Impact of network depth and image resolution on image classification. In Proceedings of the 2024 8th International Conference on Advances in Artificial Intelligence (ICAII 2024) (pp. 351-356). ACM. https://doi.org/10.1145/3704137.3704173

Gould, M. K., Donington, J., Lynch, W. R., Mazzone, P. J., Midthun, D. E., Naidich, D. P., & Wiener, R. S. (2013). Evaluation of individuals with pulmonary nodules: When is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest, 143(5 Suppl), e93S-e120S. https://doi.org/10.1378/chest.12-2351

Callister, M. E., Baldwin, D. R., Akram, A. R., Barnard, S., Cane, P., Draffan, J., ... & British Thoracic Society. (2015). British Thoracic Society guidelines for the investigation and management of pulmonary nodules. Thorax, 70(Suppl 2), ii1-ii54. https://doi.org/10.1136/thoraxjnl-2015-207168

Lanjewar, M. G., Panchbhai, K. G., & Charanarur, P. (2023). Lung cancer detection from CT scans using modified DenseNet with feature selection methods and ML classifiers. Expert Systems with Applications, 224, 119961. https://doi.org/10.1016/j.eswa.2023.119961

Eisenhauer, E. A., Therasse, P., Bogaerts, J., Schwartz, L. H., Sargent, D., Ford, R., ... & Verweij, J. (2009). New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). European Journal of Cancer, 45(2), 228-247. https://doi.org/10.1016/j.ejca.2008.10.026

Seymour, L., Bogaerts, J., Perrone, A., Ford, R., Schwartz, L. H., Mandrekar, S., ... & de Vries, E. G. E. (2017). iRECIST: Guidelines for response criteria for use in trials testing immunotherapeutics. The Lancet Oncology, 18(3), e143-e152. https://doi.org/10.1016/S1470-2045(17)30074-8

Artal-Cortés, A., Felices-Lobera, P., & Márquez-Medina, D. (2018). Massive hemoptysis after the first administration of pembrolizumab in a strongly positive, centrally located NSCLC. Journal of Thoracic Oncology, 13(5), e76-e77. https://doi.org/10.1016/j.jtho.2017.12.004

Downloads

Published

2026-05-05